Literature DB >> 6885681

Netilmicin in human CSF after parenteral administration in patients with slightly and severely impaired blood CSF barrier.

O Brückner, M Trautmann, D Kolodziejczyk, M Alexander, H Collmann.   

Abstract

After administration of 150 mg netilmicin samples of CSF and blood were obtained. In one group of nine patients with no or only slight impairment of the blood-CSF-barrier 29 samples of CSF were assayed for netilmicin concentrations. All samples, obtained after the first dose, failed to reveal detectable drug levels. Drug levels up to 0.18 mg/l were detected in samples of CSF of three patients after 3 to 22 doses. Only the lumbar CSF of one patient contained netilmicin concentrations higher than 1.0 mg/l. In comparison 19 samples of CSF, obtained from patients with meningitis after more than one dose of netilmicin, had levels of 0.27-5.0 mg/l. Three CSF samples from patients out of this group, collected after the first dose of netilmicin failed to show any drug activity.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6885681     DOI: 10.1093/jac/11.6.565

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  7 in total

1.  Cerebrospinal fluid compartmental pharmacokinetics of amikacin in neonates.

Authors:  K Allegaert; I Scheers; E Adams; G Brajanoski; V Cossey; B J Anderson
Journal:  Antimicrob Agents Chemother       Date:  2008-03-31       Impact factor: 5.191

2.  Gentamicin penetration into cerebrospinal fluid in experimental Haemophilus influenzae meningitis.

Authors:  A L Smith; R S Daum; G R Siber; D W Scheifele; V P Syriopoulou
Journal:  Antimicrob Agents Chemother       Date:  1988-07       Impact factor: 5.191

Review 3.  Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections.

Authors:  Roland Nau; Fritz Sörgel; Helmut Eiffert
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

Review 4.  Sisomicin, netilmicin and dibekacin. A review of their antibacterial activity and therapeutic use.

Authors:  P Noone
Journal:  Drugs       Date:  1984-06       Impact factor: 9.546

5.  Cerebrospinal fluid penetration of amikacin in children with community-acquired bacterial meningitis.

Authors:  J L Gaillard; C Silly; A Le Masne; B Mahut; F Lacaille; G Cheron; V Abadie; P Hubert; V Matha; C Coustere
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

6.  Intrathecal administration of netilmicin in gentamicin-resistant ventriculitis.

Authors:  E Donauer; G Drumm; J Moringlane; C Ostertag; R Kivelitz
Journal:  Acta Neurochir (Wien)       Date:  1987       Impact factor: 2.216

Review 7.  Netilmicin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Campoli-Richards; S Chaplin; R H Sayce; K L Goa
Journal:  Drugs       Date:  1989-11       Impact factor: 9.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.